Cargando…

Circulating epithelial tumor cells in patients with metastatic breast cancer treated with bevacizumab

Detalles Bibliográficos
Autores principales:	Manso, L, Ciruelos, E, Rodríguez, A, Diaz, J, Mendiola, C, López-Martín, JA, Cortes-Funes, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284911/ http://dx.doi.org/10.1186/bcr2308

Ejemplares similares

Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
por: Cortés-Funes, H, et al.
Publicado: (2009)

Lobular carcinoma of the breast: outcome of 205 patients
por: Vega, E, et al.
Publicado: (2011)

Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy
por: Manso, L, et al.
Publicado: (2011)

Efficacy and safety of the administration of bevacizumab in combination with first-line chemotherapy for the treatment of advanced breast carcinoma: ATHENA MO19391 study results in Spanish patients
por: Ciruelos, EM, et al.
Publicado: (2009)

Getting deep in the luminal B breast cancer subtype and its ki67 cut-off value
por: Ciruelos, E, et al.
Publicado: (2011)

SOLTI (Solid Tumor Intensification) Group experience with high-dose chemotherapy treatment for early breast carcinoma
por: Funes, H Cortés, et al.
Publicado: (2005)

Bevacizumab resistance in breast cancer: are neuropilins the key?
por: Staton, CA, et al.
Publicado: (2008)

microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples
por: Gámez-Pozo, A, et al.
Publicado: (2011)

The role of Xeloda in metastasic breast cancer
por: Cortés-Funes, H
Publicado: (2005)

Role of CCND1 and C-MYC oncogenes in metastatic breast cancer patients treated by herceptin
por: Trojanec, R, et al.
Publicado: (2011)

Detection of circulating cancer cells in peripheral blood as a prognostic factor in early breast cancer
por: Fabisiewicz, A, et al.
Publicado: (2005)

CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
por: Chen, Shih-Hsin, et al.
Publicado: (2015)

Predictors of toxicity for metastatic melanoma patients treated with ipilimumab
por: Valpione, Sara, et al.
Publicado: (2015)

Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients
por: Abajo, A, et al.
Publicado: (2012)

Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer
por: Galsky, Matthew D, et al.
Publicado: (2015)

Inhibition of apoptosis by Notch signalling in breast epithelial cells
por: Meurette, O, et al.
Publicado: (2008)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

You can run but you can't hide: tracking T cells in metastatic melanoma patients treated with tumor-infiltrating lymphocytes
por: Haymaker, Cara, et al.
Publicado: (2015)

Preliminary association of circulating tumor cells (CTCs) pre- and post-AdHER2 dendritic cell vaccination with overall survival in patients with metastatic HER2+ solid tumors
por: Tomita, Yusuke, et al.
Publicado: (2015)

Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel
por: Mendiola, Marta, et al.
Publicado: (2016)

Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab
por: Koguchi, Yoshinobu, et al.
Publicado: (2015)

6. Treatment resistant ulcerating dermatomyositis in metastatic melanoma treated with checkpoint inhibitor therapy
por: Parker, Lucy, et al.
Publicado: (2019)

Mirna interference in human pulmonary alveolar epithelial cells (HPAEPIC) undergoing cyclic stretch and in ex vivo ventilated and perfused rat lungs
por: Ferruelo, A, et al.
Publicado: (2015)

Future role of bevacizumab in breast cancer
por: Conte, PF, et al.
Publicado: (2009)

Circulating endothelial cells (CECS) and circulating endothelial progenitor cells (CEPCS) in septic and non-infectious systemic inflammatory response syndrome
por: Fernández, S, et al.
Publicado: (2015)

Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
por: Sznol, Mario, et al.
Publicado: (2015)

The role of neopterin in patients with primary and metastatic breast cancer: correlation with clinicopathological data
por: Demian, Soheir Rizk, et al.
Publicado: (2014)

Pharmacokinetic/pharmacodynamic analysis of linezolid in critically ill patients with severe sepsis treated with renal replacement therapy
por: Barrasa González, H, et al.
Publicado: (2015)

Circulating and tumor-based biomarkers predict clinical activity in cancer patients treated with the engineered anti-PD-L1 antibody MPDL3280A
por: Kowanetz, Marcin, et al.
Publicado: (2014)

PB.26: Significance of flat epithelial atypia at image guided breast biopsy
por: Dani, S, et al.
Publicado: (2013)

Breast carcinoma: molecular markers and subtypes to predict patients at risk of developing metastatic disease
por: Inderhaug, CR, et al.
Publicado: (2009)

Biopsy confirmation of metastatic breast cancer: interim results of a prospective biopsy study
por: Amir, E, et al.
Publicado: (2009)

Is transforming growth factor beta signalling required for breast cancer metastatic cell motility?
por: Giampieri, S, et al.
Publicado: (2006)

Discovery and characterization of an immunogenic neoantigen in a patient with metastatic triple negative breast cancer
por: Assadipour, Yasmine, et al.
Publicado: (2015)

Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis
por: Carretero-González, Alberto, et al.
Publicado: (2022)

Gene expression profile of stromal cells from potential metastatic sites in breast cancer patients
por: Del Valle, Paulo R, et al.
Publicado: (2013)

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
por: Callejo, IP, et al.
Publicado: (2005)

Stromal fibroblasts with nuclear β-catenin are present within breast tumours and increase proliferation and invasion of epithelial breast cancer cells
por: Verghese, E, et al.
Publicado: (2008)

Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients
por: Macías, J, et al.
Publicado: (2010)

Increased epithelial apoptosis and decreased oxidant injury in silymarin-treated rats with sepsis-induced acute lung injury
por: Canikli, S, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_06m1vj8971llpcj8gsbqg45nte